<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Equitable Access to Medicines</title>
    <link>https://www.taxtmi.com/news?id=23896</link>
    <description>The proposal seeks a waiver of specified TRIPS Agreement provisions to ensure intellectual property rights do not obstruct rapid scaling of manufacturing for COVID-19 vaccines, therapeutics and related goods, enabling equitable, timely and affordable access; it has been co-sponsored by numerous members and received civil society and international health support, as reported to the legislature.</description>
    <language>en-us</language>
    <pubDate>Wed, 24 Mar 2021 15:52:57 +0530</pubDate>
    <lastBuildDate>Wed, 24 Mar 2021 15:52:57 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=639761" rel="self" type="application/rss+xml"/>
    <item>
      <title>Equitable Access to Medicines</title>
      <link>https://www.taxtmi.com/news?id=23896</link>
      <description>The proposal seeks a waiver of specified TRIPS Agreement provisions to ensure intellectual property rights do not obstruct rapid scaling of manufacturing for COVID-19 vaccines, therapeutics and related goods, enabling equitable, timely and affordable access; it has been co-sponsored by numerous members and received civil society and international health support, as reported to the legislature.</description>
      <category>News</category>
      <law>-</law>
      <pubDate>Wed, 24 Mar 2021 15:52:57 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/news?id=23896</guid>
    </item>
  </channel>
</rss>